Your browser doesn't support javascript.
Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.
Baker, Emma H; Patel, Kamal; Ball, Jonathan; Edwards, Sarah; Harrison, Thomas S; Kaul, Arvind; Koh, Mickey; Krishna, Sanjeev; Leaver, Susannah; Kumar, Vinodh; Forton, Daniel M.
  • Baker EH; Institute of Infection and Immunity, St George's, University of London, London, UK.
  • Patel K; Pharmacy and Medicines Directorate, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Ball J; Department of Gastroenterology and Hepatology, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Edwards S; Adult Critical Care Directorate, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Harrison TS; Department of Science and Technology Studies, University College London, London, UK.
  • Kaul A; Institute of Infection and Immunity, St George's, University of London, London, UK.
  • Koh M; Clinical Infection Unit, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Krishna S; Department of Rheumatology, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Leaver S; Department of Haematology, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Kumar V; Institute of Infection and Immunity, St George's, University of London, London, UK.
  • Forton DM; Clinical Infection Unit, St George's University Hospitals NHS Foundation Trust, London, UK.
Br J Clin Pharmacol ; 87(3): 1584-1586, 2021 03.
Article in English | MEDLINE | ID: covidwho-643115

Full text: Available Collection: International databases Database: MEDLINE Main subject: Compassionate Use Trials / Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Bcp.14466

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Compassionate Use Trials / Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Bcp.14466